Royal Philips reported that its profits doubled year-on-year during the first quarter of 2026 [6].
The results signal a recovery for the Dutch electronics and medical technology firm as it navigates a volatile global economy marked by inflation and tariffs.
Group sales for the period reached EUR 3.9 billion [2], representing a four percent increase in comparable sales [3]. The company also saw order intake growth of six percent [1], with particularly strong performance noted in Western Europe [5].
Net profit for the first quarter of 2026 was EUR 146 million, which is approximately $171 million [4]. This is a significant increase from the EUR 72 million in net profit reported for the first quarter of 2025 [5].
Roy Jakobs, President, CEO and Chairman of the Board of Management, said, "We started '26 with a clear proof that our strategy is delivering, growth, margin expansion and strong order momentum despite the volatile environment."
Following these results, the company reiterated its full-year outlook for 2026. Philips expects annual sales growth between three percent and 4.5% [7]. The firm also maintained its adjusted EBITDA margin target of 12.5% to 13% [8].
Management said the growth was due to the successful execution of its current strategy, a move that has allowed the company to expand margins and maintain momentum despite external economic pressures.
“Profits doubled year-on-year”
The doubling of net profits and the stability of the 2026 outlook suggest that Royal Philips is successfully decoupling its growth from macroeconomic headwinds. By focusing on Western European markets and maintaining a disciplined margin, the company is demonstrating resilience against the inflationary pressures and trade tariffs that have impacted other global electronics and healthcare providers.
